These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6333639)

  • 1. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.
    Hui K; Grosveld F; Festenstein H
    Nature; 1984 Oct 25-31; 311(5988):750-2. PubMed ID: 6333639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
    Hui KM; Sim T; Foo TT; Oei AA
    J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
    Schmidt W; Festenstein H
    Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.
    James RF; Edwards S; Hui KM; Bassett PD; Grosveld F
    Immunology; 1991 Feb; 72(2):213-8. PubMed ID: 1901830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of a polymorphic class I MHC gene in the AKR lymphoma K36.16.
    Sim BC; Hui KM
    J Immunogenet; 1989; 16(4-5):335-41. PubMed ID: 2639906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of tumor growth by transfecting antisense DNA to suppress endogenous H-2Kk MHC gene expression in AKR mouse thymoma.
    Hui KM; Sim BC; Foo TT; Oei AA
    Cell Immunol; 1991 Aug; 136(1):80-94. PubMed ID: 2060026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.
    Schmidt W; Leben L; Atfield G; Festenstein H
    Immunogenetics; 1981; 14(3-4):323-39. PubMed ID: 7333657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in MHC antigenic profiles of tumor cells and its biological effects.
    Festenstein H; Schmidt W
    Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant allele-specific regulation of expression of H-2Kk gene products revealed by somatic cell hybridization.
    Bishop CE; Lewis CM; Festenstein H
    Somatic Cell Genet; 1982 Sep; 8(5):623-34. PubMed ID: 7135165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural variations in the H-2 genes of AKR lymphomas.
    Hui K; Minamide L; Prandoni N; Festenstein H; Grosveld FG
    J Immunogenet; 1986; 13(2-3):117-21. PubMed ID: 3819448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
    Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.